These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9459043

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and pharmacodynamics during treatment with the omeprazole 20 mg enteric-coated tablet and 20 mg capsule in asymptomatic duodenal ulcer patients.
    Thomson AB, Kirdeikis P, Lastiwka R, Röhss K, Sinclair P, Olofsson B.
    Can J Gastroenterol; 1997; 11(8):657-60. PubMed ID: 9459044
    [Abstract] [Full Text] [Related]

  • 3. Influence of food on the bioavailability of an enteric-coated tablet formulation of omeprazole 20 mg under repeated dose conditions.
    Thomson AB, Sinclair P, Matisko A, Rosen E, Andersson T, Olofsson B.
    Can J Gastroenterol; 1997; 11(8):663-7. PubMed ID: 9459045
    [Abstract] [Full Text] [Related]

  • 4. [Omeprazol and ezomeprazol pharmacokinetics, duration of antisecretory effect, and reasons for their probable changes in duodenal ulcer].
    Serebrova SIu, Starodubtsev AK, Pisarev VV, Kondratenko SN, Vasilenko GF, Dobrovol'skiĭ OV.
    Eksp Klin Gastroenterol; 2009; (4):86-92. PubMed ID: 19960999
    [Abstract] [Full Text] [Related]

  • 5. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole.
    Sharma VK.
    Am J Health Syst Pharm; 1999 Dec 01; 56(23 Suppl 4):S18-21. PubMed ID: 10597120
    [Abstract] [Full Text] [Related]

  • 6. The effect of the composition of a fixed dose combination on bioequivalence results.
    Šalandová J, Franc A, Hofmann J, Dumicic A, Kukačková L, Červená T, Beránek J, Srbek J, Repický A, Vladovičová B, Vetchý D.
    Int J Pharm; 2018 Jul 30; 546(1-2):235-246. PubMed ID: 29758343
    [Abstract] [Full Text] [Related]

  • 7. Bioequivalence and pharmacokinetic study of two different omeprazole capsule formulations in healthy Bangladeshi volunteers.
    Joti JJ, Nahar K, Hasan A, Azad MA, Ullah MA, Islam SM, Hasnat A.
    Arzneimittelforschung; 2009 Jul 30; 59(4):171-5. PubMed ID: 19517893
    [Abstract] [Full Text] [Related]

  • 8. Generic versus brand-name medicinal products: are they really interchangeable?
    Motola D, De Ponti F.
    Dig Liver Dis; 2006 Aug 30; 38(8):560-2. PubMed ID: 16731062
    [No Abstract] [Full Text] [Related]

  • 9. Dissolution test for liquid formulations of omeprazole enteric-coated products.
    Jang HJ, Kang BC, Shin WG, Lee S.
    Ann Pharmacother; 2003 Jan 30; 37(1):150-1. PubMed ID: 12503954
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical study on the pathophysiology and treatment of PPI-resistant ulcers.
    Ashida K, Sakaguchi M, Tanaka M, Takiuchi H, Egashira Y, Katsu K.
    J Clin Gastroenterol; 1995 Jan 30; 20 Suppl 2():S67-71. PubMed ID: 7594345
    [Abstract] [Full Text] [Related]

  • 12. Acid secretion, response to omeprazole, and Helicobacter pylori status.
    Treiber G, Klotz U.
    Am J Gastroenterol; 1997 Apr 30; 92(4):555-6. PubMed ID: 9128298
    [No Abstract] [Full Text] [Related]

  • 13. [Comparative study of proton pump inhibitors].
    Herszényi L, Tulassay Z.
    Orv Hetil; 2001 Sep 09; 142(36):1953-61. PubMed ID: 11680100
    [Abstract] [Full Text] [Related]

  • 14. Instantaneous enteric nano-encapsulation of omeprazole: pharmaceutical and pharmacological evaluation.
    Bendas ER, Abdelbary AA.
    Int J Pharm; 2014 Jul 01; 468(1-2):97-104. PubMed ID: 24746414
    [Abstract] [Full Text] [Related]

  • 15. [The MACH2 Study: value of inhibiting gastric acid secretion in eradication of Helicobacter pylori with a one week triple therapy protocol].
    Bayerdörffer E.
    Z Gastroenterol; 2000 Jan 01; 38(1):131-2. PubMed ID: 10689750
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design and in vitro/in vivo evaluation of multi-layer film coated pellets for omeprazole.
    He W, Fan LF, Du Q, Xiang B, Li CL, Bai M, Chang YZ, Cao DY.
    Chem Pharm Bull (Tokyo); 2009 Feb 01; 57(2):122-8. PubMed ID: 19182399
    [Abstract] [Full Text] [Related]

  • 20. Study of comparative bioavailability of omeprazole pellets.
    Karim S, Hay YK, Baie SH, Bukhari NI, Murtaza G.
    Acta Pol Pharm; 2014 Feb 01; 71(3):463-8. PubMed ID: 25265826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.